NEW YORK (GenomeWeb News) – ITSI-Biosciences has received a $100,000 Small Business Innovation Research grant from the National Cancer Institute to support the firm’s ongoing breast cancer biomarker program.
 
The Johnstown, Pa.-based firm is developing a biomarker-based blood test to detect and classify breast malignancies. The SBIR grant will support the development of a multiplexed assay using a suspended array technology and the development of a prototype breast disease classification, the firm said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.